Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns

Area of Science:

• Molecular biology
• Cardiovascular research
• Ion channel physiology

Background:

• Voltage-gated potassium (K(V)) channels regulate pulmonary artery smooth muscle cell (PASMC) functions.
• The K(V) channel NH(2)-terminal tetramerization domain (T1) is crucial for channel assembly and localization.
• Idiopathic pulmonary arterial hypertension (IPAH) is linked to KCNA5 gene mutations in the T1 domain.

Purpose of the Study:

• To investigate the functional and expression consequences of KCNA5 T1 domain mutations (G182R and E211D) found in IPAH patients.
• To compare the electrophysiological properties and subcellular localization of mutant K(V) channels with wild-type (WT) channels.

Main Methods:

• HEK-293 cells were transfected with WT KCNA5, G182R, E211D, or G182R/E211D constructs.
• Electrophysiological recordings (whole-cell currents) were performed to analyze channel kinetics.
• Western blotting and immunostaining were used to assess protein expression levels and subcellular localization.

Main Results:

• Mutant KCNA5 channels form functional channels but exhibit altered kinetics, specifically accelerated inactivation at more hyperpolarized potentials.
• Mutations lead to decreased channel protein expression and a higher proportion of immature glycosylated forms.
• WT K(V) channels localize to the plasma membrane, whereas mutant channels are primarily retained intracellularly.

Conclusions:

• The T1 domain of KCNA5 is essential for proper K(V) channel kinetics and trafficking to the plasma membrane.
• KCNA5 T1 domain mutations identified in IPAH patients impair channel function and localization, contributing to disease pathogenesis.